Pełna lista publikacji:

  1. Grimaldi R, Gibson GR, Vulevic J, Giallourou N, Castro-Mejía JL, Hansen LH, Leigh Gibson E, Nielsen DS, Costabile A. A prebiotic intervention study in children with autism spectrum disorders (ASDs). Microbiome. 2018;6(1):133. doi: 10.1186/s40168-018-0523-3.
    https://pmc.ncbi.nlm.nih.gov/articles/PMC6091020/pdf/40168_2018_Article_523.pdf
  2. Vulevic J, Tzortzis G, Juric A, Gibson GR. Effect of a prebiotic galactooligosaccharide mixture (B-GOS®) on gastrointestinal symptoms in adults selected from a general population who suffer with bloating, abdominal pain, or flatulence. Neurogastroenterol Motil. 2018 Nov;30(11):e13440. doi: 10.1111/nmo.13440.
    https://onlinelibrary.wiley.com/doi/10.1111/nmo.13440
  3. Huaman JW, Mego M, Manichanh C, Cañellas N, Cañueto D, Segurola H, Jansana M, Malagelada C, Accarino A, Vulevic J, Tzortzis G, Gibson G, Saperas E, Guarner F, Azpiroz F. Effects of Prebiotics vs a Diet Low in FODMAPs in Patients With Functional Gut Disorders. Gastroenterology. 2018 Oct;155(4):1004-1007. doi: 10.1053/j.gastro.2018.06.045.
    https://www.gastrojournal.org/article/S0016-5085(18)34687-0/fulltex
  4. Wilson B, Rossi M, Kanno T, Parkes GC, Anderson S, Mason AJ, Irving PM, Lomer MC, Whelan K. β-Galactooligosaccharide in Conjunction With Low FODMAP Diet Improves Irritable Bowel Syndrome Symptoms but Reduces Fecal Bifidobacteria. Am J Gastroenterol. 2020 Jun;115(6):906-915. doi: 10.14309/ajg.0000000000000641.
    https://journals.lww.com/ajg/abstract/2020/06000/\\\__galactooligosaccharide_in_conjunction_with_low.20.aspx
  5. Wilson B, Eyice Ö, Koumoutsos I, Lomer MC, Irving PM, Lindsay JO, Whelan K. Prebiotic Galactooligosaccharide Supplementation in Adults with Ulcerative Colitis: Exploring the Impact on Peripheral Blood Gene Expression, Gut Microbiota, and Clinical Symptoms. Nutrients. 2021 Oct 14;13(10):3598. doi: 10.3390/nu13103598.
    https://www.mdpi.com/2072-6643/13/10/3598
  6. Wilson B, Kanno T, Slater R, Rossi M, Irving PM, Lomer MC, Probert C, Mason AJ, Whelan K. Faecal and urine metabolites, but not gut microbiota, may predict response to low FODMAP diet in irritable bowel syndrome. Aliment Pharmacol Ther. 2023 Aug;58(4):404-416. doi: 10.1111/apt.17609.
    https://onlinelibrary.wiley.com/doi/10.1111/apt.17609
  7. Depeint F, Tzortzis G, Vulevic J, I’Anson K, Gibson GR. A prebiotic evaluation of a novel galactooligosaccharide mixture produced by the enzymatic activity of Bifidobacterium bifidum NCIMB 41171 in healthy humans: a randomized, double-blind, crossover, placebo-controlled intervention study. Am J Clin Nutr. 2008;87(3):785–791. doi: 10.1093/ajcn/87.3.785.
    https://www.medtrition.com/wp-content/uploads/2014/09/Prebiotic_evaluation_of_a_novel_galactooligosaccharide_mixture.pdf
  8. Vulevic J, Drakoularakou A, Yaqoob P, Tzortzis G, Gibson GR. Modulation of the fecal microflora profile and immune function by a novel trans-galactooligosaccharide mixture (B-GOS) in healthy elderly volunteers. Am J Clin Nutr. 2008 Nov;88(5):1438-46. doi: 10.3945/ajcn.2008.26242.
    linkinghub.elsevier.com/retrieve/pii/S0002-9165(23)23376-6
  9. Silk DBA, Davis A, Vulevic J, Tzortzis G, Gibson GR. Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome. Aliment Pharmacol Ther. 2009;29(5):508–518. doi: 10.1111/j.1365-2036.2008.03911.x.
    https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1365-2036.2008.03911.x
  10. Drakoularakou A, Tzortzis G, Rastall RA, Gibson GR. A double-blind, placebo-controlled, randomized human study assessing the capacity of a novel galacto-oligosaccharide mixture in reducing travellers’ diarrhoea. Eur J Clin Nutr. 2010 Feb;64(2):146-52. doi: 10.1038/ejcn.2009.120.
    https://www.nature.com/articles/ejcn2009124.pdf
  11. Vulevic J, Juric A, Tzortzis G, Gibson GR. A mixture of trans-galactooligosaccharides reduces markers of metabolic syndrome and modulates the fecal microbiota and immune function of overweight adults. J Nutr. 2013;143(3):324–331. doi: 10.3945/jn.112.166132.
    https://www.sciencedirect.com/science/article/pii/S0022316622011324?via%3Dihub
  12. Vulevic J, Juric A, Walton GE, Claus SP, Tzortzis G, Toward RE, Gibson GR. Influence of galacto-oligosaccharide mixture (B-GOS) on gut microbiota, immune parameters and metabonomics in elderly persons. Br J Nutr. 2015 Aug 28;114(4):586-95. doi: 10.1017/S0007114515001889.
    https://www.cambridge.org/core/journals/british-journal-of-nutrition/article/influence-of-galactooligosaccharide-mixture
  13. Schmidt K, Cowen PJ, Harmer CJ, Tzortzis G, Errington S, Burnet PWJ. Prebiotic intake reduces the waking cortisol response and alters emotional bias in healthy volunteers. Psychopharmacology. 2015;232(10):1793–1801. doi: 10.1007/s00213-014-3810-0.
    https://link.springer.com/content/pdf/10.1007/s00213-014-3810-0.pdf
  14. Williams NC, Johnson MA, Shaw DE, Spendlove I, Vulevic J, Sharpe GR, Hunter KA. A prebiotic galactooligosaccharide mixture reduces severity of hyperpnoea-induced bronchoconstriction and markers of airway inflammation. Br J Nutr. 2016 Sep;116(5):798-804. doi: 10.1017/S0007114516002762.
    https://www.cambridge.org/core/journals/british-journal-of-nutrition/article/prebiotic-galactooligosaccharide-mixture
  15. Mego M, Manichanh C, Accarino A, Campos D, Pozuelo M, Varela E, Vulevic J, Tzortzis G, Gibson G, Guarner F, Azpiroz F. Metabolic adaptation of colonic microbiota to galactooligosaccharides: a proof-of-concept-study. Aliment Pharmacol Ther. 2017 Mar;45(5):670-680. doi: 10.1111/apt.13931.
    https://onlinelibrary.wiley.com/doi/abs/10.1111/apt.13931
  16. Hasle G, Raastad R, Bjune G, Jenum PA, Heier L. Can a galacto-oligosaccharide reduce the risk of traveller’s diarrhoea? A placebo-controlled, randomized, double-blind study. J Travel Med. 2017 Sep 1;24(5). doi: 10.1093/jtm/tax057.
    https://academic.oup.com/jtm/article-abstract/24/5/tax057/4085921
  17. Kao AC, Safarikova J, Marquardt T, Mullins B, Lennox BR, Burnet PWJ. Pro-cognitive effect of a prebiotic in psychosis: A double blind placebo controlled cross-over study. Schizophr Res. 2019 Jun;208:460-461. doi: 10.1016/j.schres.2019.03.003.
    linkinghub.elsevier.com/retrieve/pii/S0920-9964(19)30085-4
  18. Capitão LP, Baião R, Baek HK, Kappelmann N, Sharman R, Harvey CJ, Montgomery P, Burnet PW. Prebiotic supplementation does not affect reading and cognitive performance in children: A randomised placebo-controlled study. J Psychopharmacol. 2020 Jan;34(1):148-152. doi: 10.1177/0269881119862534.
    https://journals.sagepub.com/doi/10.1177/0269881119862534
  19. Parker C, Hunter KA, Johnson MA, Sharpe GR, Gibson GR, Walton GE, Poveda C, Cousins B, Williams NC. Effects of 24-week prebiotic intervention on self-reported upper respiratory symptoms, gastrointestinal symptoms, and markers of immunity in elite rugby union players. Eur J Sport Sci. 2023 Nov;23(11):2232-2239. doi: 10.1080/17461391.2023.2216657.
    https://onlinelibrary.wiley.com/doi/10.1080/17461391.2023.2216657